Akintunde Akinleye

2.0k total citations · 1 hit paper
13 papers, 1.5k citations indexed

About

Akintunde Akinleye is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Akintunde Akinleye has authored 13 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 5 papers in Genetics and 5 papers in Oncology. Recurrent topics in Akintunde Akinleye's work include Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Cancer Mechanisms and Therapy (3 papers). Akintunde Akinleye is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Cancer Mechanisms and Therapy (3 papers). Akintunde Akinleye collaborates with scholars based in United States, China and Nigeria. Akintunde Akinleye's co-authors include Delong Liu, Muhammad Furqan, Nikhil Mukhi, Yamei Chen, Yongping Song, Varun Mittal, Yongping Song, Shundong Cang, Chaitanya Iragavarapu and A.A. Ajayi and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Hematology & Oncology and Oncotarget.

In The Last Decade

Akintunde Akinleye

12 papers receiving 1.5k citations

Hit Papers

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics 2019 2026 2021 2023 2019 100 200 300 400 500

Peers

Akintunde Akinleye
Ling Cen United States
Joe Stephenson United States
Christine Fritsch Switzerland
Linda Mora United States
Theresa A. Mays United States
Akintunde Akinleye
Citations per year, relative to Akintunde Akinleye Akintunde Akinleye (= 1×) peers Yongping Song

Countries citing papers authored by Akintunde Akinleye

Since Specialization
Citations

This map shows the geographic impact of Akintunde Akinleye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akintunde Akinleye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akintunde Akinleye more than expected).

Fields of papers citing papers by Akintunde Akinleye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akintunde Akinleye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akintunde Akinleye. The network helps show where Akintunde Akinleye may publish in the future.

Co-authorship network of co-authors of Akintunde Akinleye

This figure shows the co-authorship network connecting the top 25 collaborators of Akintunde Akinleye. A scholar is included among the top collaborators of Akintunde Akinleye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akintunde Akinleye. Akintunde Akinleye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Akinleye, Akintunde, et al.. (2025). Complexities of managing refractory hypoglycemia in a rare case of metastatic grade 2 pancreatic neuroendocrine tumor.. Journal of Clinical Oncology. 43(16_suppl).
2.
Akinleye, Akintunde, et al.. (2019). Immune checkpoint inhibitors of PD-L1 as cancer therapeutics. Journal of Hematology & Oncology. 12(1). 92–92. 539 indexed citations breakdown →
3.
Iragavarapu, Chaitanya, Akintunde Akinleye, Muhammad Furqan, et al.. (2015). Novel ALK inhibitors in clinical use and development. Journal of Hematology & Oncology. 8(1). 17–17. 82 indexed citations
4.
Akinleye, Akintunde, Chaitanya Iragavarapu, Muhammad Furqan, Shundong Cang, & Delong Liu. (2015). Novel agents for advanced pancreatic cancer. Oncotarget. 6(37). 39521–39537. 26 indexed citations
5.
Furqan, Muhammad, Akintunde Akinleye, Judy Sarungbam, et al.. (2014). Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock. Frontiers of Medicine. 8(2). 254–258. 2 indexed citations
6.
Akinleye, Akintunde, et al.. (2013). MEK and the inhibitors: from bench to bedside. Journal of Hematology & Oncology. 6(1). 27–27. 236 indexed citations
7.
Furqan, Muhammad, Akintunde Akinleye, Nikhil Mukhi, et al.. (2013). STAT inhibitors for cancer therapy. Journal of Hematology & Oncology. 6(1). 90–90. 154 indexed citations
8.
Wu, Mei‐Hwan, Akintunde Akinleye, & Xiongpeng Zhu. (2013). Novel agents for chronic lymphocytic leukemia. Journal of Hematology & Oncology. 6(1). 36–36. 24 indexed citations
9.
Akinleye, Akintunde, Muhammad Furqan, & Oluwaseyi Adekunle. (2013). Ibrutinib and Indolent B-Cell Lymphomas. Clinical Lymphoma Myeloma & Leukemia. 14(4). 253–260. 13 indexed citations
10.
Akinleye, Akintunde, Yamei Chen, Nikhil Mukhi, Yongping Song, & Delong Liu. (2013). Ibrutinib and novel BTK inhibitors in clinical development. Journal of Hematology & Oncology. 6(1). 59–59. 186 indexed citations
11.
Akinleye, Akintunde, et al.. (2013). Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics. Journal of Hematology & Oncology. 6(1). 88–88. 219 indexed citations
12.
Ajayi, A.A., et al.. (1991). The effects of prednisolone and niacin on chloroquine-induced pruritus in malaria. European Journal of Clinical Pharmacology. 41(4). 383–385. 12 indexed citations
13.
Ajayi, A.A., et al.. (1989). Epidemiology of antimalarial-induced pruritus in Africans. European Journal of Clinical Pharmacology. 37(5). 539–540. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026